These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2505052)

  • 1. Mutagenesis by aflatoxin in M13 DNA: base-substitution mechanisms and the origin of strand bias.
    Sahasrabudhe S; Sambamurti K; Humayun MZ
    Mol Gen Genet; 1989 May; 217(1):20-5. PubMed ID: 2505052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of mutagenesis by a bulky DNA lesion at the guanine N7 position.
    Sambamurti K; Callahan J; Luo X; Perkins CP; Jacobsen JS; Humayun MZ
    Genetics; 1988 Dec; 120(4):863-73. PubMed ID: 3147220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of base substitutions induced by the acridine mutagen ICR-191: mispairing by guanine N7 adducts as a mutagenic mechanism.
    Sahasrabudhe SR; Luo X; Humayun MZ
    Genetics; 1991 Dec; 129(4):981-9. PubMed ID: 1783299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of frameshift mutagenesis by aflatoxin B1-2,3-dichloride.
    Refolo LM; Bennett CB; Humayun MZ
    J Mol Biol; 1987 Feb; 193(4):609-36. PubMed ID: 3112409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SOS and MucAB functions on reactivation and mutagenesis of M13 replicative form DNA bearing bulky lesions.
    Bennett CB; Luo X; Refolo LM; Humayun MZ
    Mutat Res; 1988 Nov; 202(1):223-34. PubMed ID: 3141805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational properties of the primary aflatoxin B1-DNA adduct.
    Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA replication-blocking properties of adducts formed by aflatoxin B1-2,3-dichloride and aflatoxin B1-2,3-oxide.
    Jacobsen JS; Refolo LM; Conley MP; Sambamurti K; Humayun MZ
    Mutat Res; 1987 Jul; 179(1):89-101. PubMed ID: 3110609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of G.C to A.T transitions by the acridine half-mustard ICR-191 supports a mispairing mechanism for mutagenesis by some bulky mutagens.
    Sahasrabudhe SR; Luo X; Humayun MZ
    Biochemistry; 1990 Dec; 29(49):10899-905. PubMed ID: 2271689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli.
    Foster PL; Groopman JD; Eisenstadt E
    J Bacteriol; 1988 Aug; 170(8):3415-20. PubMed ID: 3136139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mutations by replication of malondialdehyde-modified M13 DNA in Escherichia coli: determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced.
    Benamira M; Johnson K; Chaudhary A; Bruner K; Tibbetts C; Marnett LJ
    Carcinogenesis; 1995 Jan; 16(1):93-9. PubMed ID: 7834810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repair of thymine.guanine and uracil.guanine mismatched base-pairs in bacteriophage M13mp18 DNA heteroduplexes.
    Shenoy S; Ehrlich KC; Ehrlich M
    J Mol Biol; 1987 Oct; 197(4):617-26. PubMed ID: 3323525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational specificity of aflatoxin B1. Comparison of in vivo host-mediated assay with in vitro S9 metabolic activation.
    Prieto-Alamo MJ; Jurado J; Abril N; Díaz-Pohl C; Bolcsfoldi G; Pueyo C
    Carcinogenesis; 1996 Sep; 17(9):1997-2002. PubMed ID: 8824526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Base substitution mutations induced by metabolically activated aflatoxin B1.
    Foster PL; Eisenstadt E; Miller JH
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2695-8. PubMed ID: 6405385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of mutagenesis by the vinyl chloride metabolite chloroacetaldehyde. Effect of gene-targeted in vitro adduction of M13 DNA on DNA template activity in vivo and in vitro.
    Jacobsen JS; Humayun MZ
    Biochemistry; 1990 Jan; 29(2):496-504. PubMed ID: 2405905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic requirements for frameshift reversion induced by bulky DNA adducts in M13 DNA.
    Bennett CB; Luo X; Humayun MZ
    Mutat Res; 1991 Jul; 249(1):19-27. PubMed ID: 2067532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.
    Smela ME; Hamm ML; Henderson PT; Harris CM; Harris TM; Essigmann JM
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6655-60. PubMed ID: 12011430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity.
    Koch WH; Henrikson EN; Kupchella E; Cebula TA
    Carcinogenesis; 1994 Jan; 15(1):79-88. PubMed ID: 8293552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Escherichia coli UVM response is accompanied by an SOS-independent error-prone DNA replication activity demonstrable in vitro.
    Al Mamun AA; Yadava RS; Ren L; Humayun MZ
    Mol Microbiol; 2000 Oct; 38(2):368-80. PubMed ID: 11069662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinds of mutations induced by aflatoxin B1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNA.
    Trottier Y; Waithe WI; Anderson A
    Mol Carcinog; 1992; 6(2):140-7. PubMed ID: 1326989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the binding site of aflatoxin B1 in DNA: systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences.
    Benasutti M; Ejadi S; Whitlow MD; Loechler EL
    Biochemistry; 1988 Jan; 27(1):472-81. PubMed ID: 2831961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.